GlassScriptPhysician profile
Francis J Cavanaugh
NPI 1033165998
$1,732.05
in general payments reported to CMS, 2019-2025
16 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $139 · 2021: $161 · 2022: $112 · 2023: $39.42 · 2024: $245 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $230.26 | 2024-2025 | Evenity, Krystexxa, Prolia |
| Melinta Therapeutics, LLC | $214.27 | 2019-2020 | |
| Pfizer INC. | $202.88 | 2019-2025 | |
| Novo Nordisk INC | $184.80 | 2021-2025 | Ozempic |
| Allergan, INC. | $174.82 | 2019-2020 | |
| Boston Scientific Corporation | $163.74 | 2024 | Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals LP | $126.55 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $105.40 | 2025 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $89.92 | 2019-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.01 | 2021-2025 | Jardiance |
| Abbvie INC. | $56.69 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $37.84 | 2020-2023 | Xarelto |
| Echosens North America, INC. | $27.71 | 2025 | Fibroscan |
| Exact Sciences Corporation | $27.16 | 2025 | The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $15.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Cavanaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.